NASDAQ : CALC
CalciMedica, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 1.46 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 9.97M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 7.08M | 7.89M | 9.73M | 9.52M | 5.84M | 5.06M |
| Research & Development | 12.54M | 15.23M | 14.48M | 12.36M | 8.35M | 16.48M |
| Operating Expenses | 19.63M | 23.12M | 24.20M | 21.88M | 14.19M | 21.54M |
| Operating Income | -19.63M | -23.12M | -24.20M | -21.88M | -14.19M | -21.54M |
| Interest Expense | -1.29M | -1.42M | -132.00K | |||
| Interest & Investment Income | 451.00K | 713.00K | 1.01M | |||
| Other Non Operating Income (Expenses) | -770.00K | -5.73M | 9.49M | 3.72M | 3.76M | -1.96M |
| EBT Excluding Unusual Items | -21.24M | -29.56M | -13.70M | -18.16M | -10.57M | -23.50M |
| Merger & Restructuring Charges | -16.20M | |||||
| Other Unusual Items | 2.75M | |||||
| Pretax Income | -21.24M | -29.56M | -13.70M | -34.36M | -7.82M | -23.50M |
| Net Income | -21.24M | -29.56M | -13.70M | -34.36M | -7.82M | -23.50M |
| Preferred Dividends & Other Adjustments | 1.32M | |||||
| Net Income to Common | -21.24M | -29.56M | -13.70M | -34.36M | -9.14M | -23.50M |
| Shares Outstanding (Basic) | 3.19M | 3.00M | 2.25M | 897.25K | 16.45K | 543.21K |
| Shares Outstanding (Diluted) | 3.19M | 3.00M | 2.25M | 897.25K | 16.45K | 543.21K |
| EPS (Basic) | -6.65 | -9.85 | -6.09 | -38.29 | -555.78 | -43.26 |
| EPS (Diluted) | -6.65 | -9.85 | -6.09 | -38.29 | -555.78 | -43.26 |
| Free Cash Flow | -19.12M | -21.21M | -21.15M | -25.81M | -11.76M | -20.72M |
| Free Cash Flow Per Share | -5.99 | -7.06 | -9.40 | -28.76 | -715.00 | -38.14 |
| EBITDA | -19.59M | -23.07M | -24.15M | -21.82M | -14.14M | -21.50M |
| D&A For EBITDA | 31.00K | 46.00K | 58.00K | 58.00K | 52.00K | 42.00K |
| EBIT | -19.63M | -23.12M | -24.20M | -21.88M | -14.19M | -21.54M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 18.62M | 11.52M | 7.93M | 5.53M | 1.33M | 4.76M |
| Short-Term Investments | 1.50M | 10.73M | 5.71M | |||
| Cash & Short-Term Investments | 18.62M | 13.02M | 18.67M | 11.24M | 1.33M | 4.76M |
| Prepaid Expenses | 803.00K | 460.00K | 996.00K | 367.00K | 254.00K | 170.00K |
| Restricted Cash | 149.00K | |||||
| Other Current Assets | 43.00K | 54.00K | ||||
| Total Current Assets | 19.46M | 13.53M | 19.66M | 11.61M | 1.73M | 4.93M |
| Property, Plant & Equipment | 36.00K | 50.00K | 119.00K | 167.00K | 195.00K | 386.00K |
| Long-Term Deferred Charges | 1.11M | |||||
| Other Long-Term Assets | 4.00K | 11.00K | 10.00K | 413.00K | 1.42M | 35.00K |
| Total Assets | 19.50M | 13.59M | 19.79M | 12.19M | 3.35M | 6.46M |
| Accounts Payable | 2.07M | 1.16M | 2.00M | 1.42M | 2.87M | 1.93M |
| Accrued Expenses | 1.42M | 1.37M | 1.69M | 2.61M | 1.72M | 1.83M |
| Current Portion of Long-Term Debt | 1.25M | |||||
| Current Portion of Leases | 156.00K | |||||
| Other Current Liabilities | 199.00K | |||||
| Total Current Liabilities | 3.49M | 3.78M | 3.68M | 4.03M | 4.78M | 3.92M |
| Long-Term Debt | 9.20M | 8.45M | ||||
| Long-Term Leases | 39.00K | |||||
| Other Long-Term Liabilities | 1.30M | 8.00M | 1.70M | 7.80M | 4.42M | |
| Total Liabilities | 13.99M | 20.23M | 5.38M | 4.03M | 12.58M | 8.38M |
| Common Stock | 6.00K | 4.00K | 4.00K | 1.00K | 1.00K | 3.00K |
| Additional Paid-In Capital | 197.51M | 182.68M | 174.17M | 154.22M | 40.40M | 39.89M |
| Retained Earnings | -192.00M | -189.33M | -159.76M | -146.06M | -111.71M | -103.88M |
| Comprehensive Income & Other | -1.00K | 4.00K | 2.00K | |||
| Total Common Equity | 5.51M | -6.64M | 14.41M | 8.16M | -71.30M | -63.99M |
| Shareholders' Equity | 5.51M | -6.64M | 14.41M | 8.16M | -9.23M | -1.92M |
| Total Liabilities & Equity | 19.50M | 13.59M | 19.79M | 12.19M | 3.35M | 6.46M |
| Total Debt | 9.20M | 9.70M | 195.00K | |||
| Net Cash (Debt) | 9.42M | 3.32M | 18.67M | 11.24M | 1.33M | 4.57M |
| Net Cash Per Share | 2.95 | 1.10 | 8.30 | 12.52 | 80.67 | 8.41 |
| Filing Date Shares Outstanding | 6.83M | 3.15M | 2.70M | 2.15M | 2.92M | 2.92M |
| Total Common Shares Outstanding | 6.15M | 3.09M | 2.70M | 1.15M | 2.92M | 2.73M |
| Working Capital | 15.97M | 9.75M | 15.98M | 7.58M | -3.05M | 1.01M |
| Book Value Per Share | 0.90 | -2.15 | 5.34 | 7.09 | -24.40 | -23.47 |
| Tangible Book Value | 5.51M | -6.64M | 14.41M | 8.16M | -71.30M | -63.99M |
| Tangible Book Value Per Share | 0.90 | -2.15 | 5.34 | 7.09 | -24.40 | -23.47 |
| Machinery | 241.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -21.24M | -29.56M | -13.70M | -34.36M | -7.82M | -23.50M |
| Depreciation & Amortization | 31.00K | 46.00K | 58.00K | 58.00K | 52.00K | 42.00K |
| Loss (Gain) From Sale of Investments | -132.00K | -346.00K | -608.00K | -145.00K | ||
| Stock-Based Compensation | 2.35M | 2.97M | 2.31M | 12.04M | 1.81M | 2.11M |
| Other Operating Activities | 1.00M | 6.34M | -8.71M | -3.06M | -6.40M | 1.96M |
| Change in Accounts Payable | -865.00K | -840.00K | 601.00K | -1.43M | 933.00K | -251.00K |
| Change in Other Net Operating Assets | -218.00K | 217.00K | -1.10M | 1.16M | -328.00K | -873.00K |
| Operating Cash Flow | -19.11M | -21.18M | -21.15M | -25.73M | -11.76M | -20.51M |
| Capital Expenditures | -14.00K | -28.00K | -8.00K | -78.00K | -4.00K | -211.00K |
| Investment in Securities | 12.17M | 9.58M | -4.42M | 8.96M | ||
| Investing Cash Flow | 12.20M | 9.55M | -4.42M | 8.88M | -4.00K | -211.00K |
| Long-Term Debt Issued | 9.66M | 8.46M | ||||
| Net Debt Issued (Repaid) | 9.66M | 8.46M | ||||
| Issuance of Common Stock | 19.60M | 5.55M | 27.97M | 10.59M | 18.00K | 8.00K |
| Other Financing Activities | 10.31M | -773.00K | ||||
| Financing Cash Flow | 19.60M | 15.21M | 27.97M | 20.90M | 8.48M | 20.55M |
| Net Cash Flow | 12.70M | 3.58M | 2.40M | 4.05M | -3.29M | -167.00K |
| Free Cash Flow | -19.12M | -21.21M | -21.15M | -25.81M | -11.76M | -20.72M |
| Free Cash Flow Per Share | -5.99 | -7.06 | -9.40 | -28.76 | -715.00 | -38.14 |
| Levered Free Cash Flow | -10.54M | -13.02M | -13.74M | -2.37M | -6.31M | -12.61M |
| Unlevered Free Cash Flow | -9.73M | -12.13M | -13.74M | -2.37M | -6.23M | -12.61M |
| Change in Working Capital | -1.08M | -623.00K | -495.00K | -267.00K | 605.00K | -1.12M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 9.76M | 94.96M | 47.73M | 16.26M | ||
| Enterprise Value | 347.46K | 89.77M | 33.12M | 1.67M | ||
| Last Close Price | 1.46 | 32.95 | 17.70 | 14.30 | ||
| PB Ratio | 1.63 | -14.30 | 3.31 | 1.99 | ||
| P/TBV Ratio | 1.81 | 3.31 | 1.99 | |||
| Debt / Equity Ratio | 1.67 | -1.46 | -0.10 | |||
| Net Debt / Equity Ratio | -1.71 | 0.50 | -1.30 | -1.38 | 0.14 | 2.38 |
| Net Debt / EBITDA Ratio | 0.48 | 0.14 | 0.77 | 0.52 | 0.09 | 0.21 |
| Net Debt / FCF Ratio | 0.49 | 0.16 | 0.88 | 0.43 | 0.11 | 0.22 |
| Quick Ratio | 5.33 | 3.44 | 5.07 | 2.79 | 0.28 | 1.22 |
| Current Ratio | 5.58 | 3.58 | 5.34 | 2.88 | 0.36 | 1.26 |
| Return on Equity (ROE) | -365.70% | -761.02% | -121.42% | |||
| Return on Assets (ROA) | -63.58% | -86.57% | -94.61% | -176.03% | -180.79% | -220.50% |
| Return on Capital Employed (ROCE) | -122.60% | -235.70% | -150.20% | -268.20% | 991.80% | -846.00% |
| Earnings Yield | -465.23% | -31.13% | -28.71% | -211.31% | ||
| FCF Yield | -191.79% | -22.33% | -44.32% | -158.73% | ||
| Buyback Yield / Dilution | -19.98% | -33.48% | -150.68% | -5,354.75% | 96.97% | -3.08% |